Radiofrequency ablation of pancreatic serous cystic neoplasms: feasibility, but for the wrong indication

Endoscopy 2021; 53(06): 666
DOI: 10.1055/a-1323-2782

Letter to the editor

Authors

Diane Lorenzo

¹Endoscopy Unit, Beaujon Hospital, Clichy La Garenne, APHP, France
Benedicte Jais

¹Endoscopy Unit, Beaujon Hospital, Clichy La Garenne, APHP, France
Philippe Levy

²Pancreatology unit, Beaujon Hospital, Clichy La Garenne, APHP, France

References
1 Oh D, Ko SW, Seo D-W. et al. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic microcystic serous cystic neoplasms: a retrospective study. Endoscopy 2020;
2 Jais B, Rebours V, Malleo G. et al. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut 2016; 65: 305-312
3 Elta GH, Enestvedt BK, Sauer BG. et al. ACG Clinical Guideline: Diagnosis and management of pancreatic cysts. Am J Gastroenterol 2018; 113: 464-479
4 European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018; 67: 789-804
5 Barthet M, Giovannini M, Lesavre N. et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study. Endoscopy 2019; 51: 836-842